Recruitment Temporarily Suspended into C.E.R.A. Phase II Oncology Trial
February 24th, 2007
Roche announced today that it is temporarily suspending recruitment into its Phase II dose-finding study (NH19960) with the investigational drug C.E.R.A. in anaemic patients with advanced non small cell lung cancer receiving chemotherapy.